Delia Alvarez

A Phase I First-in-Human Study of TRC105 (Anti-Endoglin Antibody) in Patients with Advanced Cancer

Lee S. Rosen, Herbert I. Hurwitz, Michael K. Wong et al. · Clinical Cancer Research · 2012 · 171 citations · Full text

Pharmacy, Oncology, Pharmacokinetics +17

An Open-Label Phase Ib Dose-Escalation Study of TRC105 (Anti-Endoglin Antibody) with Bevacizumab in Patients with Advanced Cancer

Michael S. Gordon, Francisco Robert, Daniela Matei et al. · Clinical Cancer Research · 2014 · 68 citations · Full text

Medicine, Oncology, Pharmacology +17

Feature Selection Algorithms Using Rough Set Theory

Yailé Caballero Mota, Delia Alvarez, Rafael Bello et al. · Seventh International Conference on Intelligent Systems Design and Applications (ISDA 2007) · 2007 · 36 citations

Computing, Computer Science, Data Mining +14

KRYSTAL-12: A randomized phase 3 study of adagrasib (MRTX849) versus docetaxel in patients (pts) with previously treated non-small-cell lung cancer (NSCLC) with KRAS^G12C mutation.

Tony Mok, William Lawler, M. Shum et al. · Journal of Clinical Oncology · 2021 · 31 citations

Medicine, Oncology, Pharmacology +17

Modulation of Circulating Protein Biomarkers in Cancer Patients Receiving Bevacizumab and the Anti-Endoglin Antibody, TRC105

Yingmiao Liu, Mark D. Starr, John C. Brady et al. · Molecular Cancer Therapeutics · 2018 · 25 citations

Medicine, Oncology, Pharmacology +17